Potential Uses Include: Biomarker of Immunity to SARS-CoV-2; Personalized Approach to Timing COVID-19 Vaccine Boosters; Public Health Surveillance; and Serving as an Endpoint for COVID-19 Vaccine Trials
Student entrepreneurs win $10,000 in MSU’s annual Big Idea Challenge
Their ideas included a virtual reality textbook, a new building material, a food incubator, a device to assist construction workers, various software solutions and a student-focused professional networking platform.
UM vaccine research expands, soon to conduct clinical trials
As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.
MBA announces 2021 Hall of Fame Inductee
The Montana BioScience Alliance is pleased to announce that Michelle Hood has been inducted into the 2021 MBA Hall of Fame. Ms. Hood is Executive Vice President and Chief Operating Officer of the American Hospital Association and was instrumental in the formation of the Montana BioScience Alliance.
Montana State researchers help advance sleep-aid device
Soon, someone feeling the need for some extra Z’s may benefit from a wearable device that aids the brain in the biochemical cleansing that leaves a person feeling refreshed after a full night of sleep. As part of the first large-scale study on the effectiveness of the new technology, Montana State University researchers will analyze brain scans of participants who wear a prototype of the device, which works by applying precise electrical stimulation to the brain. The project, which involves multiple universities, is funded by $4.3 million from the Department of Defense.
New UM program fast tracks future Montana pharmacists
University of Montana first-year student Tori Matteson can’t point to a specific event that peaked her interest in becoming a pharmacist – there aren’t any in her family – but her curiosity about medicine started early in her high school years growing up in Butte. When it came time to enroll in college…she said it was “UM all the way.”
InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters
Montana company Solo-Dex has entered into an agreement for its proprietary continuous nerve block catheters with InfuSystem, a leading national healthcare service provider.
UM vaccine research expands, soon to conduct clinical trials
As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.
Billings Clinic participating in a clinical trial for an alternative treatment to long term blood thinners in patients with atrial fibrillation
Billings Clinic is participating in a national trial to study the use of an advanced device to treat patients with atrial fibrillation who are at higher risk for stroke and we are enrolling participants now.
Called the CHAMPION-AF trial and initiated by Boston Scientific, it is a randomized head-to-head trial designed to evaluate the safety and efficacy of the next-generation WATCHMAN FLX Left Atrial Appendage Closure Device within a broad population of patients with non-valvular atrial fibrillation (AF), including those who are at low-to-moderate risk of bleeding from the use of blood thinners. The device will be compared to results from leading contemporary blood thinner medications for stroke risk reduction in this population and provide a procedural option for those who may not otherwise qualify for the WATCHMAN device.